{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:21:13Z","timestamp":1786123273298,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1213\/ane.0b013e3181cfc307","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T05:34:32Z","timestamp":1268890472000},"page":"1195-1197","source":"Crossref","is-referenced-by-count":7,"title":["Successful Treatment of a Patient with Trigeminal Neuropathy Using Ziconotide"],"prefix":"10.1213","volume":"110","author":[{"given":"Eberhard Albert","family":"Lux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-34-20210902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2000.tb00134.x","article-title":"Analgesic properties of Ziconotide, a selective blocker of N-type neuronal calcium channels.","volume":"6","author":"Wang","year":"2000","journal-title":"CNS Drug Rev"},{"key":"R2-34-20210902","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/sa.2000.6787","article-title":"Ziconotide: a new pharmaceutical class of drug for the management of pain.","volume":"19","author":"Mathur","year":"2000","journal-title":"Semin Anaesth Perioper Med Pain"},{"key":"R3-34-20210902","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomised, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.","volume":"31","author":"Rauck","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"R4-34-20210902","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic non-malignant pain: a randomised, double-blind, placebo-controlled clinical trial.","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"key":"R5-34-20210902","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"key":"R6-34-20210902","first-page":"1","article-title":"Cerebrospinal fluid circulation and associated intracranial dynamics. A radiologic investigation using MR imaging and radionuclide cisternography.","volume":"386","author":"Greitz","year":"1993","journal-title":"Acta Radiol Suppl"},{"key":"R7-34-20210902","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0091270003253349","article-title":"Pharmacokinetics and pharmacodynamics of intrathecal Ziconotide in chronic pain patients.","volume":"43","author":"Wermeling","year":"2003","journal-title":"J Clin Pharmacol"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e3181cfc307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:16:12Z","timestamp":1786112172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201004000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181cfc307","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}